linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Valiant Laboratories Ltd.
 
Source DateBoard Meeting DateDetails
06 Nov 202511 Nov 2025 Quarterly Results
05 Aug 202508 Aug 2025 Quarterly Results
07 Jul 202509 Jul 2025 Inter alia, to consider and approve the proposal for raising of funds by way of issue of securities through further public offer, rights issue, American Depository Receipts/ Global Depository Receipts/ Foreign Currency Convertible Bonds, qualified institutions placement, debt issue, preferential issue or any other method as may be decided and considered appropriate, subject to such regulatory/statutory approvals as may be required, and matters related and incidental thereto.
14 May 202520 May 2025 Audited Results
31 Jan 202507 Feb 2025 Quarterly Results
07 Nov 202412 Nov 2024 Quarterly Results & Audited Results
06 Aug 202412 Aug 2024 Quarterly Results
07 May 202414 May 2024 Audited Results
01 Feb 202409 Feb 2024 Quarterly Results & Audited Results
30 Oct 202306 Nov 2023 Quarterly Results
Page 1 of 1
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.